White Paper

Capturing Promotion Response: How Panel Analysis can improve the accuracy of Predictive Analysis

Market Research

Share on facebook
Share on twitter
Share on linkedin

Businesses are thirsty for a competitive edge. Harnessing the power of predictive analytics in bringing medicines to market can provide valuable insights to drive that advantage, and when put into practice, can have far reaching implications to the future of life sciences. Predictive analytics in the life sciences industry has long struggled to cope with the challenges of identifying and decoding the complexity of human behavior and its changes over time; however, if used correctly today, it can help optimize commercialization with planning, production, and distribution. The basis of a valuable predictive analysis lies in its handling of seemingly “unexplainable” events – events whose impact on the desired response is difficult to estimate and extract. For example, when trying to estimate the impact of field calls on product sales, it is important to understand and extract the impact of unexplainable environmental factors such as political events, market trends, seasonal trends, etc. away from the desired impact of field calls. In order to discover the true patterns of such underlying opportunities as Rx trend or behavior, one must remove or minimize as much as possible the impact these unexplainable events have on the analysis, keeping in mind the primary measurement of success for predictive analytics is how well it reflects reality. From a life sciences commercialization perspective, promotion response has been a chronic victim of these persistent unexplainable events inadvertently influencing the desired response. Proper modeling with panel analysis can largely alleviate any undesired impact and yield a more accurate promotion response. Click on link to read more.

For Questions, Contact Us Now

Related insights

KMK Donates to COVID Relief Effort in India


Making Remote Work in India with Pratik Panchal

KMK Consulting, Inc. Earns 2021 Great Place to Work Certification™

Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

KMK Welcomes Oncology Market Research Veteran Lisa Logan

The Ultimate Plan for Strong Analytics Support to Drive Business Decisions : A no-compromise solution on quality and value

A Roadmap to Success: Five Guiding Principles to Incentive Compensation Planning

Pharma Companies’ Sales Reporting Efforts Often Fall Short. A look at why this occurs and how to avoid it in the future.

KMK Value Based Medicine

Unlock forward looking Insights via Machine Learning

GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma

Gritty and Fearless: How to succeed at KMK

East Meets West: The KMK Way

Learning the Ropes: An Intern’s Story at KMK

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

Readjusting Your Field Force in the World of COVID-19

How to Reach Oncologists when Face-to-Face Interaction is Impossible

KMK’s Split Credit Tool Improves IC Performance

KMK’s Employee Performance Tool Streamlines HQ/Sales Rep Calibration

Field Force Re-Optimization in Anticipation of Loss of Exclusivity (LOE)

IC Plan Design in Defense of Competitive Entry

Sales Force Effectiveness for Top 20 Pharma

Please fill the form below

Privacy Notice


KMK Consulting Inc. is committed to protecting and respecting your privacy. The information you provide will not be used for other commercial purposes nor will it be sold, rented, leased or forwarded to any third party. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you, and you may unsubscribe from these communications at any time. By clicking the send you agree to receive other communication from KMK Consulting Inc.